Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis

Vascular inflammation initiated by oxidized lipoproteins drives initiation, progression, and even rupture of atherosclerotic plaques. Yet, to date, no biomarker is directly linked to oxidized lipid-induced vascular inflammation. Reticulocalbin 2 (RCN2) is a key regulator of basal and oxidized lipid-...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing, Taylor, Angela M., Manichaikul, Ani, Angle, John F., Shi, Weibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997427/
https://www.ncbi.nlm.nih.gov/pubmed/35406670
http://dx.doi.org/10.3390/cells11071107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997427/
https://www.ncbi.nlm.nih.gov/pubmed/35406670
http://dx.doi.org/10.3390/cells11071107

Ejemplares similares